NCT04903132View on ClinicalTrials.gov

Cellular Senescence and COVID-19 Long-Hauler Syndrome

Active, not recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

SARS-CoV2 Infection

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04903132 - Cellular Senescence and COVID-19 Long-Hauler Syndrome | Biotech Hunter | Biotech Hunter